Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
Arnold
G
G
Trenkwalder
C
C
Schwarz
J
J
Oertel
W H
WH
D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003988:Dibenzothiepins / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D009127:Muscle Rigidity / Q000209:etiology*; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D011605:Psychoses, Substance-Induced / Q000188:drug therapy*; D014202:Tremor / Q000188:drug therapy*
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D003988:Dibenzothiepins; D007980:Levodopa; C022172:zotepine